Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Lancet Haematol. 2022 Jul 27;9(9):e660–e669. doi: 10.1016/S2352-3026(22)00206-X

Table 1:

Baseline characteristics of transplant recipients and haploidentical donors

Study cohort (n=31)
Sex
   Female 12 (39%)
   Male 19 (61%)

Race and ethnicity
   Non-Hispanic White 12 (39%)
   Hispanic White 4 (13%)
   Non-Hispanic Black 7 (23%)
   Hispanic Black 0
   Asian or Pacific Islander 5 (16%)
   Native American 0
   More than one race 1 (3%)
   Unknown 2 (6%)

Age, years 24·9 (10·4–51·3)
   <10 years 7 (23%)
   10–19 years 6 (19%)
   20–29 years 5 (16%)
   30–39 years 1 (3%)
   40–49 years 4 (13%)
   50–59 years 2 (6%)
   60–69 years 5 (16%)
   ≥70 years 1 (3%)

Interval from diagnosis to transplantation, months 10·8 (8·1–32·0)
   ≤6 months 5 (16%)
   >6 and ≤12 months 11 (35%)
   >12 and ≤18 months 4 (13%)
   >18 and ≤24 months 1 (3%)
   >24 and ≤30 months 1 (3%)
   >30 and ≤36 months 3 (10%)
   >36 and ≤42 months 1 (3%)
   >42 and ≤48 months 0
   >48 and ≤54 months 2 (6%)
   >54 and ≤60 months 1 (3%)
   >60 and ≤66 months 0
   >66 and ≤72 months 0
   >72 months 2 (6%)

Donor age, years 38·6 (26·9–46·5)

Donor relationship
   Related haploidentical 31 (100%)

Donor sex
   Female 18 (58%)
   Male 13 (42%)

Donor/recipient cytomegalovirus serostatus at baseline
   +/+ 17 (55%)
   +/− 2 (6%)
   −/+ 4 (13%)
   −/− 7 (23%)
   Missing 1 (3%)

Data are n (%) or median (IQR).